Chronic HBV Infection Study: A study of Entecavir in Blacks/African Americans and Hispanics with chronic HBV infection.

HIV AIDS Clinical Trial: This study at Rush University Medical Center in Chicago, Illinois, will assess the safety of a new experimental drug. The drug is one of the subtypes of the natural IL protein produced in the body.

HIV AIDS Clinical Trial: A Phase IIIB, Randomized, Trial of Open-label Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) with another PI in Combination with Double-Blind Comparison of two Nucleoside Reverse Transcriptase Inhibitor (NRTI) or a different NRTI in Antiretroviral-NaWve Subjects

HIV AIDS Clinical Trial HAART: The purpose of the research is to see if anti-HIV vaccine is safe and tolerable in subjects infected with HIV.

HIV Infection (Initial Therapy): A phase III, randomized, open-label study of initial therapy for HIV-1 infection

HIV/AIDS Clinical Trial: The study is being done at Rush University Medical Center in Chicago, Illinois, to learn if treating people during early HIV infection is beneficial. This study will evaluate how safe and effective a combination of anti-HIV drugs is for people with recently acquired HIV infection.

HIV/AIDS Clinical Trial: The study at Rush University Medical Center in Chicago, Illinois, will try to see if taking a nucleoside supplement is safe in HIV-infected persons and if it will reverse the loss of fat in the face, arms, legs, or buttocks.

Hepatitis C Study Using Antiviral Treatment: Study of a thrombopoietin receptor agonist, for 12 weeks in subjects with chronic hepatitis C-related thrombocytopenia who are potential candidates for antiviral treatment with pegylated interferon and ribavirin.

Policosonal for Dyslipidemia in HIV: Policosonal for dyslipidemia in HIV

Study Of TYZEKA with Compensated Chronic Hepatitis B Virus Infection: Study of TYZEKA in subjects of Black/African American or Hispanic/Latino origin with compensated chronic hepatitis B virus infection